𝔖 Bobbio Scriptorium

✦ LIBER ✦

Recombinant vaccines for hepatitis E

✍ Scribed by Suzanne U Emerson; Robert H Purcell

Book ID: 117787746
Publisher: Elsevier Science
Year: 2001
Tongue: English
Weight: 50 KB
Volume: 7
Category: Article
ISSN: 1471-4914
DOI: 10.1016/s1471-4914(01)02106-2

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Establishment and validation of an ELISA

Establishment and validation of an ELISA for the quantitation of HBsAg in recombinant hepatitis B vaccines

✍ Catia Inês Costa; Isabella Fernandes Delgado; Jaline Alves Cabral da Costa; Rena 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 342 KB

New vaccines against hepatitis C virus;

New vaccines against hepatitis C virus; recombinant envelope protein production by vector expression in e.g. Escherichia coli, for application as a recombinant vaccine : SK Beecham Biol. World 9701 640; 16 January 1997

📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 385 KB

Acid-fast bacterium-Escherichia coli shu

Acid-fast bacterium-Escherichia coli shuttle vector; gene cloning and expression in e.g. Mycobacterium bovis BCG for multivalent recombinant vaccine production, e.g. against Mycobacterium tuberculosis or hepatitis B virus

📂 Article 📅 1993 🏛 Elsevier Science 🌐 English ⚖ 125 KB

New mosaic hepatitis E virus polypeptide

New mosaic hepatitis E virus polypeptides; recombinant protein production by vector expression for use as a recombinant vaccine : U.S. Dep. Health Hum. Serv. Nat. Inst. Health Bethesda World 9521 858; 17 August 1995

📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 173 KB

Use of Conventional or Replicating Nucle

Use of Conventional or Replicating Nucleic Acid-Based Vaccines and Recombinant Semliki Forest Virus-Derived Particles for the Induction of Immune Responses Against Hepatitis C Virus Core and E2 Antigens

✍ O. Vidalin; A. Fournillier; N. Renard; M. Chen; E. Depla; D. Boucreux; C. Brinst 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 283 KB

New mammalian expression systems for HCV

New mammalian expression systems for HCV proteins; hepatitis C virus recombinant E1 and E2 fusion protein preparation by vector plasmid pHCV-172, plasmid pHCV-351 and plasmid pHCV-425 expression for use in recombinant vaccine : Abbott Lab World 9520 664; 3 August 1995

📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 152 KB